E. Becht, N. Giraldo, and C. Germain, Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers, Adv Immunol, vol.130, 2016.
DOI : 10.1016/bs.ai.2015.12.002

W. Fridman, F. Pagès, C. Sautès-fridman, and J. Galon, The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012.
DOI : 10.1200/JCO.2010.30.6308

D. Hanahan and L. Coussens, Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment, Cancer Cell, vol.21, issue.3, pp.309-322, 2012.
DOI : 10.1016/j.ccr.2012.02.022

E. Becht, N. Giraldo, and M. Dieu-nosjean, Cancer immune contexture and immunotherapy, Current Opinion in Immunology, vol.39, 2016.
DOI : 10.1016/j.coi.2015.11.009
URL : https://hal.archives-ouvertes.fr/hal-01281664

F. Pagès, A. Berger, and M. Camus, Effector memory T cells, early metastasis, and survival in colorectal cancer Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin, N Engl J Med Clinical Cancer Research, vol.353, issue.19, pp.2654-26664079, 2005.

M. Postow, M. Callahan, and J. Wolchok, Immune Checkpoint Blockade in Cancer Therapy, Journal of Clinical Oncology, vol.33, issue.17, pp.1974-1982, 2015.
DOI : 10.1200/JCO.2014.59.4358

R. Kontermann and U. Brinkmann, Bispecific antibodies, Drug Discovery Today, vol.20, issue.7, pp.838-847, 2015.
DOI : 10.1016/j.drudis.2015.02.008

Y. Guo, Y. Wang, and W. Han, Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects, Journal of Immunology Research, vol.13, issue.15, pp.3850839-3850849, 2016.
DOI : 10.1089/cbr.2008.0533

J. Galon, A. Costes, and F. Sanchez-cabo, Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006.
DOI : 10.1126/science.1129139

N. Giraldo, E. Becht, and F. Pagès, Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer, Clinical Cancer Research, vol.21, issue.13, pp.3031-3040, 2015.
DOI : 10.1158/1078-0432.CCR-14-2926

C. Granier, C. Dariane, and P. Combe, T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma, Cancer Research, vol.77, issue.5, pp.1075-1082, 2017.
DOI : 10.1158/0008-5472.CAN-16-0274

S. Shen-orr and R. Gaujoux, Computational deconvolution: extracting cell type-specific information from heterogeneous samples, Current Opinion in Immunology, vol.25, issue.5, pp.571-578, 2013.
DOI : 10.1016/j.coi.2013.09.015

D. Venet, F. Pecasse, C. Maenhaut, and H. Bersini, Separation of samples into their constituents using gene expression data, Bioinformatics, vol.17, issue.Suppl 1, pp.279-287, 2001.
DOI : 10.1093/bioinformatics/17.suppl_1.S279

A. Abbas, K. Wolslegel, and D. Seshasayee, Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer, PLOS ONE Immunity, vol.4, issue.39, pp.782-795, 2009.

Y. ?enbabao?lu, R. Gejman, and A. Winer, Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures doi: 10.1186/s13059-016-1092-z 18 Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade Robust enumeration of cell subsets from tissue expression profiles, Genome Biol Cell Rep Nat Methods, vol.17, issue.12, pp.231248-262453, 2015.

E. Becht, N. Giraldo, and L. Lacroix, Estimating the??population abundance of tissue-infiltrating immune and stromal cell populations using gene expression, Genome Biology, vol.52, issue.Suppl 2, pp.218-228, 2016.
DOI : 10.1172/JCI107470
URL : https://hal.archives-ouvertes.fr/hal-01398093

G. Quon, S. Haider, and A. Deshwar, Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction, Genome Medicine, vol.5, issue.3, 2013.
DOI : 10.1038/ng.259

N. Giraldo, E. Becht, and Y. Vano, Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma, Clinical Cancer Research, vol.23, issue.15, 2017.
DOI : 10.1158/1078-0432.CCR-16-2848

T. Choueiri and R. Motzer, Systemic Therapy for Metastatic Renal-Cell Carcinoma, New England Journal of Medicine, vol.376, issue.4, 2017.
DOI : 10.1056/NEJMra1601333

T. Bauman, W. Huang, M. Lee, and E. Abel, Neovascularity as a prognostic marker in renal cell carcinoma, Human Pathology, vol.57, issue.57, pp.354-366, 2016.
DOI : 10.1016/j.humpath.2016.07.005

M. Dieu-nosjean, J. Goc, and N. Giraldo, Tertiary lymphoid structures in cancer and beyond, Trends in Immunology, vol.35, issue.11, pp.571-580, 2014.
DOI : 10.1016/j.it.2014.09.006

M. Dieu-nosjean, N. Giraldo, and H. Kaplon, Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers, Immunological Reviews, vol.9, issue.Suppl 3, pp.260-275, 2016.
DOI : 10.1371/journal.pone.0099008

T. Schumacher and R. Schreiber, Neoantigens in cancer immunotherapy, Science, vol.43, issue.D1, pp.69-74, 2015.
DOI : 10.1093/nar/gku1075

A. Alizadeh, M. Eisen, and R. Davis, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, vol.303, issue.6769, pp.503-511, 2000.
DOI : 10.7326/0003-4819-127-3-199708010-00002

T. Ando, M. Suguro, and T. Kobayashi, Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling, Cancer Science, vol.5, issue.10, pp.906-913, 2003.
DOI : 10.1182/blood.V98.4.945

M. Guedj, L. Marisa, and A. De-reynies, A refined molecular taxonomy of breast cancer, Oncogene, vol.10, issue.9, pp.1196-1206747, 1038.
DOI : 10.1038/nature09515
URL : https://hal.archives-ouvertes.fr/inserm-00611752

J. Guinney, R. Dienstmann, and X. Wang, The consensus molecular subtypes of colorectal cancer, Nature Medicine, vol.228, issue.11, pp.1350-1356, 2015.
DOI : 10.1186/gb-2004-5-10-r80

E. Becht, A. De-reyniès, and N. Giraldo, Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy, Clinical Cancer Research, vol.22, issue.16, pp.4057-4066, 2016.
DOI : 10.1158/1078-0432.CCR-15-2879

D. Le, J. Uram, and H. Wang, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, New England Journal of Medicine, vol.372, issue.26, pp.2509-2520, 2015.
DOI : 10.1056/NEJMoa1500596

R. Dienstmann, L. Vermeulen, and J. Guinney, Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer, Nature Reviews Cancer, vol.34, issue.2, pp.79-92, 2017.
DOI : 10.1126/scitranslmed.aaf6219

B. Beuselinck, S. Job, and E. Becht, Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting, Clinical Cancer Research, vol.21, issue.6, pp.1329-1339, 2015.
DOI : 10.1158/1078-0432.CCR-14-1128

E. Becht, N. Giraldo, and B. Beuselinck, Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC), OncoImmunology, vol.61, issue.12, 2015.
DOI : 10.1158/0008-5472.CAN-08-2654